Lung Cancer
Volume 55, Issue 1 , Pages 95-99 , January 2007

Lessons to learn from EORTC study 08981: A feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer

  • V. Surmont

      Affiliations

    • Department of Pulmonology, Erasmus MC-Daniel Den Hoed Cancer Center, Groene Hilledijk 301, 3008 AE Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 10 4391437; fax: +31 10 4391044.
    • ,
  • R.J. van Klaveren

      Affiliations

    • Department of Pulmonology, Erasmus MC-Daniel Den Hoed Cancer Center, Groene Hilledijk 301, 3008 AE Rotterdam, The Netherlands
    • ,
  • C. Goor

      Affiliations

    • Department of Radiotherapy, AZ Middelheim, Antwerp, Belgium
    • ,
  • F. Schramel

      Affiliations

    • Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • C. Manegold

      Affiliations

    • Department of Medical Oncology, Thoraxklinik Rohrbach, Heidelberg, Germany
    • ,
  • C. Legrand

      Affiliations

    • European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium
    • ,
  • P. Van Schil

      Affiliations

    • Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Belgium
    • ,
  • J.P. Van Meerbeeck

      Affiliations

    • Department of Pulmonology, University of Ghent, Belgium

Received 10 April 2006 ,Revised 4 September 2006 ,Accepted 23 September 2006.

References 

  1. Rowell NP, O’ Rourke NP. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2004 (October 18 (4)) CD002140 [Review].
  2. Albain KS, Rusch VW, Crowley JJ, Rice TW, Tuirisi AT, Weick JK, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest oncology group phase II study 8805. J Clin Oncol. 1995;13:1880–1892
  3. Choi NG, Carey RW, Daly W, Mathisen D, Wain J, Wright C, et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small cell lung cancer. J Clin Oncol. 1997;15:712–722
  4. Betticher DC, Hsu Schmitz SF, Totsch M, Hansen E, Joss C, von Briel C, et al. Mediastinal lymph node clearance after docetaxel-cisplatin chemotherapy is prognostic of survival in patients with IIIA pN2 NSCLC: a muli-center phase II trial. J Clin Oncol. 2003;21:1752–1759
  5. Van Meerbeeck J, Kramer G, Van Schil P, Legrand C, Smit EF, Schramel FM, et al. A randomized trial of radical surgery versus thoracic radiotherapy in patients with stage IIIA-N2 NSCLC after response to induction chemotherapy (EORTC 08941). J Clin Oncol. 2005;23(16S):1095s;(abstract 7015)
  6. Bueno R, Richards WG, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, et al. Nodal stage after inducton therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg. 2000 Dec;70(6):1826–1831
  7. Roth JA, Fosella F, Komaki R, Ryan MB, Putnam JB, Lee JS, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Nat Cancer Inst. 1994;86:673–680
  8. Roth JA, Atkinson EN, Fosella F, Komaki R, Bemadette Ryan M, Putman JB, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer. 1998;21:1–6
  9. Resell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, et al. A randomized trail comparing perioperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153–158
  10. Rusch VW, Albain KS, Crowley JJ. Neoadjuvant therapy: a novel and effective treatment for stage IIIB non-small cell lung cancer. Ann Thorac Surg. 1994;58:290–295
  11. Rice TW, Adelstein DJ, Koka A. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer. Ann Thorac Surg. 1995;60:586–592
  12. Rice TW, Adelstein DJ, Ciczki JP, Becker ME, Rybicki LA, Farver CF, et al. Short-course induction chemoradiotherapy with paclitaxel for stage III non-small cell lung cancer. Ann Thorac Surg. 1998;66:1909–1914
  13. Eberhardt W, Wilke H, Stamatis G, Sluschkc M, Harstrick A, Menker H, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: mature results of a phase II trial. J Clin Oncol. 1998;16:622–634
  14. Thomas M, Rube C, Semik M, von Eiff M, Freitag L, Macha HN, et al. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small cell lung cancer. J Clin Oncol. 1999;17:1185–1193
  15. Sugarbaker DJ, Herndon J, Kohman LJ, Krasna MJ, Green MR. Results of CALGB 8935 a multi-institutional phase II trimodality trial for stage IIIA (N2) non-small cell lung cancer. J Thorac Cardiovasc Surg. 1995;109:473–485
  16. Stamatis G, Eberhard W, Pöttgen C. Surgery after multimodality treatment for non-small-cell lung cancer. Lung Cancer. 2004;45(Suppl. 2):S107–S112
  17. Grunenwald D, Andre F, Le Péchoux C, Girard P, Lamer C, Laplanche A, et al. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg. 2001;122:796–802
  18. Albain KS, Swann RS, Rusch VR, Tumsi AT, Sheperd FA, Smith CJ, et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer: outcomes update of North American Intergroup 0139 ( RTOG 9309). J Clin Oncol. 2005;23(16S):624S;(abstract 7014)
  19. Mateu-Navarro M, Rami-Porta R, Bastus-Piulats R, Cirera-Nogueras L, Gonzalez-Pont G. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg. 2000;70:391–395
  20. Thall PF, Simon R, Ellenberg SS. A two-stage design for choosing among several experimental treatments and a control in clinical trials. Biometrics. 1989;45:537–547
  21. Machtay M, Seiferheld W, Komaki R, Cox JD, Sause WT, Beyhardt RW. Is prolonged survival possible for patients with supraclavicular nodes metastases in NSCLC treated with chemoradiotherapy: analysis of the radiation therapy oncology group experience. Int J Radiat Oncol Biol Phys. 1999;44:847–853
  22. Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, et al. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with stage III NSCLC. Int J Rad Oncol Biol Phys. 2005;63:1037–1044
  23. Cesario A, Margaritora S, Trodella L, Valente S, Corbo GM, Maeis G, et al. Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer. Lung Cancer. 2002;37:207–212
  24. Trodella L, Granone P, Valcntc S, Turriziani A, Macis G, Corbo GM, et al. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non small cell lung cancer. J Clin Oncol. 2002;20:804–810
  25. Van Schil P, van der Schoot J, Poniewierski J, Pauwels M, Carp L, Gennonpre P, et al. Remediastinoscopy after neoadjuvant therapy for non small cell lung cancer. Lung Cancer. 2002;37:281–285
  26. Cesario A, Margaritora S, Porziella V, Granone P. Intrathoracic staging in non small cell lung cancer: re-do mediastinoscopy revisited. Lung Cancer. 2003;40:227–228
  27. Pauwels M, Van Schil P, De Backer W, Van den Brande F, Eyskens E. Repeat mediastinoscopy in the staging of lung cancer. Eur J Cardiothorac Surg. 1998;14:271–273
  28. Meersschaut D, Vermassen F, Brutel de la Riviere A, Knaepen PJ, Van den Bosch JM, Vanderschueren R. Repeat mediastinoscopy in the assessment of new and recurrent lung neoplasm. Ann Thorac Surg. 1992;53:120–122
  29. Olsen PS, Stentoft P, Ellefsen B, Petterson G. Re-mediastinoscopy in the assessment of resectability of lung cancer. Eur J Cardiol Thorac Surg. 1997;11:661–663
  30. De Leyn P, Stroobants S, Vansteenkiste J. Prospective study of accuracy of redo videomediastinoscopy and PET-CT in detecting residual mediastinal disease after induction chemotherapy for NSCLC. Lung Cancer. 2005;49(Suppl. 2):S3 (Pr2)
  31. Annema JJ, Veselic M, Versteeg MI, Willems LN, Rabe KF. Mediastinal restaging: EUS-FNA offers a new perspective. Lung Cancer. 2003;42:311–318
  32. Junker K. Histopathologic evaluation of mediastinal lymph nodes in lung cancer. Lung Cancer. 2004;45(Suppl. 2):S79–S83
  33. Caddy G, Conron M, Wright G, Desmond P, Hart D, Chen RY. The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur Respir J. 2005;25:410–415
  34. Eloubeidi MA, Tamhane A, Chen VK, Cerfolio RJ. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy. Ann Thorac Surg. 2005;80:1231–1239
  35. Larsen SS, Vilmann P, Krasnik M, Dirksen A, Clementsen P, Maltbaek N, et al. Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging. Lung Cancer. 2005;48(1):85–92
  36. Vilmann P, Krasnik M, Larsen SS, Jacobsen GK, Clementsen P. Transesophageal endoscopic ultrasound guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) biopsy: a combined approach in the evaluation of mediastinal lesions. Endoscopy. 2005;37:833–839
  37. Vansteenkiste J, Fischer BM, Dooms C, Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol. 2004;5:531–540
  38. Detterbeck F, Vansteenkiste J, Morris DE, Dooms CA, Khandani AH, Socinski MA. Emerging applications of positron emission tomography imaging in the management of patients with lung cancer. Chest. 2004;126:1656–1666
  39. Wright CD, Mathisen DJ. Sulcus superior tumors. Curr Treat Options Oncol. 2001;2(1):43–49
  40. Farray D, Mirkovic N, Albain KS. Multimodality therapy for stage III non-small-cell lung cancer. J Clin Oncol. 2005;23(14):3257–3269
  41. Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Johnson D, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the sulcus superior: initial results of SWOG Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg. 2001;121(3):472–483

PII: S0169-5002(06)00523-X

doi: 10.1016/j.lungcan.2006.09.015

Lung Cancer
Volume 55, Issue 1 , Pages 95-99 , January 2007

Article Tools